References:
1) Palaskar S., Koshti S., Maralingannavar M., Bartake A. Inflammatory myofibroblastic tumor. Contemp. Clin. Dent. 2011;2(4):274–277.
2) Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North Am. 2016 May;54(3):553-63. doi: 10.1016/j.rcl.2015.12.005. Epub 2016 Mar 12. PMID: 27153788.
3) Do BA, Varshney R, Zawawi F, Levental M, Caglar D, Young J. Inflammatory myofibroblastic tumor of the larynx-a case report. J Voice. 2014 Mar;28(2):258-61. doi: 10.1016/j.jvoice.2013.09.004. Epub 2013 Dec 8. PMID: 24321588.
4) Ni C, Xu YY, Zhou SH, Wang SQ. Differential diagnosis of inflammatory myofibroblastic tumour and low-grade myofibroblastic sarcoma: two case reports with a literature review. J Int Med Res.2011;39(1):311-20. doi: 10.1177/147323001103900134. PMID: 21672335.
5) Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T. Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26920. Epub 2017 Dec 29. PMID: 29286567.